Primecap Management Portfolio holdings
AUM
$126B
1-Year Return
17.42%
This Quarter Return
+8.4%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$149B
AUM Growth
+$5.43B
(+3.8%)
Cap. Flow
-$4.43B
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Top Buys
| 1 |
SPLK
Splunk Inc
SPLK
|
$172M |
| 2 |
Alibaba
BABA
|
$118M |
| 3 |
XPeng
XPEV
|
$103M |
| 4 |
Raymond James Financial
RJF
|
$71M |
| 5 |
Allogene Therapeutics
ALLO
|
$59.2M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$326M |
| 2 |
NetApp
NTAP
|
$247M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$230M |
| 4 |
Adobe
ADBE
|
$228M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$219M |
Sector Composition
| 1 | Technology | 30.45% |
| 2 | Healthcare | 26.97% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
nVent Electric
NVT
$14.8B
| $27.7M | 0.02% |
887,900
| – | – |
|
227
LPL Financial
LPLA
$28.8B
| $27.5M | 0.02% |
204,000
| – | – |
|
228
Comscore
SCOR
$32.8M
| $27.3M | 0.02% |
273,352
-1,046
| -0.4% | -$105K |
|
229
Kirby Corp
KEX
$5.03B
| $27.3M | 0.02% |
450,100
| – | – |
|
230
BridgeBio Pharma
BBIO
$9.91B
| $27.2M | 0.02% |
446,860
+91,623
| +26% | +$5.59M |
|
|
NUVA
231
DELISTED
NuVasive, Inc.
NUVA
| $26.4M | 0.02% |
388,800
-10,200
| -3% | -$691K |
|
232
Xometry
XMTR
$2.5B
| $26.2M | 0.02% |
+300,000
| New | +$26.2M |
|
233
Ulta Beauty
ULTA
$23.7B
| $26M | 0.02% |
75,300
| – | – |
|
234
Matsons
MATX
$3.32B
| $25M | 0.02% |
390,592
-1,700
| -0.4% | -$109K |
|
235
NN Inc
NNBR
$131M
| $24.8M | 0.02% |
3,376,100
-1,678,591
| -33% | -$12.3M |
|
236
American Homes 4 Rent
AMH
$12.8B
| $24.6M | 0.02% |
633,550
-235,650
| -27% | -$9.15M |
|
237
GSK
GSK
$79.8B
| $22M | 0.01% |
441,120
-6,320
| -1% | -$315K |
|
238
Brinker International
EAT
$7.11B
| $21.7M | 0.01% |
+351,200
| New | +$21.7M |
|
|
CALA
239
DELISTED
Calithera Biosciences, Inc
CALA
| $21.6M | 0.01% |
517,185
+500
| +0.1% | +$20.9K |
|
|
DOOR
240
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $21.6M | 0.01% |
193,200
+19,700
| +11% | +$2.2M |
|
241
Rapid7
RPD
$1.28B
| $19.4M | 0.01% |
205,400
-1,300
| -0.6% | -$123K |
|
242
Amicus Therapeutics
FOLD
$2.47B
| $17.8M | 0.01% |
1,845,000
-285,000
| -13% | -$2.75M |
|
243
Guardant Health
GH
$7.65B
| $17.5M | 0.01% |
140,952
| – | – |
|
244
Snap
SNAP
$12B
| $17.3M | 0.01% |
253,600
| – | – |
|
|
GTM
245
ZoomInfo Technologies
GTM
$3.22B
| $16.9M | 0.01% |
323,839
+4,750
| +1% | +$248K |
|
246
Danaher
DHR
$143B
| $16.6M | 0.01% |
+69,965
| New | +$16.6M |
|
247
Philip Morris
PM
$251B
| $15.4M | 0.01% |
155,000
| – | – |
|
248
Saic
SAIC
$4.98B
| $14.7M | 0.01% |
167,800
| – | – |
|
249
Waters Corp
WAT
$17.8B
| $14.2M | 0.01% |
40,998
| – | – |
|
250
Cameco
CCJ
$33.2B
| $14M | 0.01% |
730,700
-6,000
| -0.8% | -$115K |
|